Chartpoppers.com releases Investment overview on Inspire Pharmaceuticals Inc.

( CHARTPOPPERS.COM, March 10, 2010 ) The Consolidated investment Analysis on Inspire Pharmaceuticals Inc. (NASDAQ: ISPH) will be in particular interest to other competing companys within in its sector, such as Bristol Myers Squibb Co. (NYSE:BMY), Merck & Co. Inc. (NYSE: MRK) and Johnson & Johnson. (NYSE: JNJ)

Point Roberts, WA - Chartpoppers.com announces an investment report featuring company Inspire Pharmaceuticals Inc. (NASDAQ: ISPH)

Inspire Pharmaceuticals, Inc. (Inspire) biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. The Company's portfolio of products and product candidates include Elestat, Restasis, AzaSite, Prolacria and Denufosol tetrasodium.

To view the Consolidated Investment Analysis on Inspire Pharmaceuticals Inc. (NASDAQ: ISPH) Please visit the stock pulse page at http://www.chartpoppers.com

In the report chartpoppers.com covers a recent Financial Summary, Analyst Consensus, Technical Analysis, Comparative Analysis and Insider Trading Activity.

The full report is available at http://www.chartpoppers.com

Chartpoppers.com is a market research and investment commentary provider. Chartpoppers.com aims to bring undervalued, up and coming companies into the sight of both experienced and non-experienced investors. We try to help investors, at whatever stage in their careers, to get a grasp on the necessary financial data that they need in order to make a educated investment decision. From our daily trading ideas to a in depth coverage of what's going on in the markets, we are sure that chartpoppers.com is exactly what you need in order succeed.

For More information please visit us at http://www.chartpoppers.com

Chartpoppers.com Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. ChartPoppers.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.


CHARTPOPPERS.COM
Paul Marek
6047245332
info@chartpoppers.com

Source: EmailWire.Com